WBP2 and breast carcinoma: Analysis of the gene copy number alterations and mRNA expression of the WBP2 gene in multiple large-scale breast cancer datasets such as The Cancer Genome Atlas (TCGA) [48] and METABRIC [49, 50] indicated that WBP2 is frequently amplified (4.1–25%) or gained (0–31.7%) in breast cancer patients, whereas deletion was barely present [33].